Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2025-04-02 00:00:00 ET · period of report 2025-03-31 · accession 0001127602-25-011136 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-02 | 2025-03-31 | BCRX | Thackray Helen M. | Chief R, D Off | F - Tax | $7.50 | -7,525 | 377.3K | -2% | -$56.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-31 | F | D | 7,525 | $7.50 | 377,318 | D | — | — | (F1) Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person. |